Jefferies Raises PT On Seattle Genetics To $25

July 15, 2011 7:19 AM | 8 seconds read |
Jefferies & Company has raised the price target on Seattle Genetics SGEN from $22 to $25 and maintains its Buy rating.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Price TargetAnalyst RatingsBiotechnologyHealth CareJefferies & Company
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!